News Archive

  • December 2009

    Recipharm Sales and Marketing Agreement

    Focus Pharmaceuticals is delighted to announce that it has been appointed by Recipharm AB as the exclusive sales and marketing partner for a range of products that Recipharm have recently purchased from UCB Pharma Limited. The range of products comprises 54 individual product lines that are both branded and generic prescription only medicines. Focus will commence distribution of these products from 7th of December 2009.

    This agreement includes the sales and marketing activities for the products in the UK and Ireland, and extends the range of products Focus manages for the Recipharm Group of companies.

  • September 2009

    New Product Launch – Ondansetron Oral Liquid 4mg per 5ml…

    Focus is pleased to announce the launch of Ondansetron Oral Liquid 4mg per 5ml to the market. This product is the first generic competitor to Zofran Liquid in the UK.

  • August 2009

    Interim Financial Results - 6 months to 30th June 2009 (unaudited)…

    Focus continued to grow in the First Half of 2009 and showed double digit growth in turnover and gross profit compared to the first 6 months of 2008. The main financial highlights for the first half were

    - Turnover growth of 19% vs. last year
    - Gross profit showed growth of 11% vs. last year

    The Company expects to launch more products to the market in the second half of the year, adding to the growth achieved in the first half.

    (Please note that these numbers are unaudited)

  • April 2009

    Focus launches Citalopram Drops…

    Focus is proud to announce that it has launched another product onto the market. April saw the launch of Citalopram Drops which is another niche product for launch on the generic market in the UK.

  • August 2008

    Focus opens a new Operations Centre in Wigan…

    Focus has just opened a new state of the art Operations Centre in Hindley Green, Wigan. The warehouse is 8000 square ft, and has been fitted out to a very high specification. The facility has been approved by the MHRA and is large enough to help Focus grow in the future. This facility also gives the business a solid foundation and flexibility to react quickly to customer needs.